Search results
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 5 days agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
Here's Why We Think AstraZeneca (LON:AZN) Is Well Worth Watching
Simply Wall St. via Yahoo Finance· 2 days agoIf this kind of company isn't your style, you like companies that generate revenue, and even earn...
AstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline Expansion
The Wall Street Journal· 5 days agoAstraZeneca has set out a new revenue target as it aims to bolster its investment in technologies...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks via Yahoo Finance· 6 days agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody...
From In-House at AstraZeneca to an E-Discovery Startup: New Fileread GC Discusses Major Career Move...
Law.com· 6 days agoThe latest: E-discovery startup Fileread, which announced in early May that it hired the head of...
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
Zacks via Yahoo Finance· 2 days agoAstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 5 days agoA Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
AstraZeneca to build $1.5bn ADCs facility in Singapore
Investment Monitor via Yahoo Finance· 6 days agoPharmaceutical giant AstraZeneca has announced plans to invest $1.5bn in a new antibody-drug...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 5 days agoThe Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai,...
AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Kingsview Wealth Management LLC
ETF DAILY NEWS· 4 days agoKingsview Wealth Management LLC grew its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 11.3% during the 4th quarter, according to the company in its most recent disclosure ...